| 今开：0.0 | 昨收：0.11 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：7026799.0 |
淘沙见金2017-10-26 21:30
$Achaogen, Inc.(AKAO)$ Achaogen (NASDAQ:AKAO) is up 6% premarket on light volume in response to its announcement that it has submitted a New Drug Application (NDA) to the FDA seeking approval for aminoglycoside antibiotic plazomicin for the treatment of complicated urinary ...查看全文
淘沙见金2017-10-09 22:28
$Achaogen, Inc.(AKAO)$ 股价已经基本快跌到年初三期成功后的水平了，原因还是管理层对NDA以及生产工厂问题没有跟市场进行明确的沟通。肯定有不耐心的投资者要跳船了，现在买进就是看管理层会不会像他们说的可以在年底之前提交新药申请。否则，股价下10也不是不可能。查看全文
淘沙见金2017-09-12 02:57
Pfizer's EpiPen manufacturer warned by FDA. The FDA's warning looks to be the culmination of several voluntary recalls Mylan enacted in the spring for EpiPen product coming from St. Louis-based Meridian.除了$Mylan(MYL)$ ,辉瑞的这家药厂坑了不少公司啊，$Achaogen, Inc.(A...查看全文
淘沙见金2017-08-30 11:04
觉得MDCO Fully Valued的理由：（1）Carbavance 300mm/year sale. P/S =6. Worth 1.4 bn present value, equals $19 per share. (2) Inclisiran 600mm/year peak sale. P/S = 3 worth $ 12 per share. 有的Analysts觉得这个资产值 $ 20 - $ 30， 我是不赞同的。(3) 现有的业务折合股价$ 7左右。 我...查看全文
淘沙见金2017-08-30 06:50
$麦迪逊医药(MDCO)$ FDA批准了MDCO治疗尿路感染的联合方案。虽然我觉得公司已经fully valued, 明天可能有10%-15%的涨幅。明天可以关注一下 $Achaogen, Inc.(AKAO)$ 的股价会不会受影响。查看全文
淘沙见金2017-08-21 05:36
IBB/XBI
从过去十年的数据来看，IBB$美国生科ETF-iShares(IBB)$ 在八月份表现一向不好，平均的回报是-2.2%。2017年的八月份也不例外，在七月份达到$330的高点之后，IBB一路下滑，回撤了将近10%。这种表现跟行业缺乏并购、地缘政治风险、板块之间的轮转以及投资者锁利有关。XBI的表现也是类似，...查看全文
淘沙见金2017-07-18 09:54
Paratek 在今天收盘后公布了一天一次、口服Omadacycline针对ABSSI治疗的结果，研究结果满足了FDA/EMA所规定的主要和次要要求。
药效方面，对比Linezolid，Omadacycline满足了 10% 非劣性临床研究（ non-inferiority）的要求。
考虑到之前已有的两个成功的三期实验，这一点并不让人意外。...查看全文
$Achaogen(AKAO)$ EFFECT - Notice of Effectiveness Filed: 2019-08-20 AccNo: 9999999995-19-001929 Size: 1 KB 网页链接
$Achaogen(AKAO)$ EFFECT - Notice of Effectiveness Filed: 2019-08-20 AccNo: 9999999995-19-001930 Size: 1 KB 网页链接
$Achaogen(AKAO)$ POS AM - Post-Effective amendments for registration statement Filed: 2019-08-16 AccNo: 0001193125-19-223513 Size: 21 KB 网页链接
$Achaogen(AKAO)$ POS AM - Post-Effective amendments for registration statement Filed: 2019-08-16 AccNo: 0001193125-19-223516 Size: 21 KB 网页链接
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223522 Size: 24 KB 网页链接
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223523 Size: 24 KB 网页链接
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223527 Size: 24 KB 网页链接
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223530 Size: 24 KB 网页链接
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223534 Size: 24 KB 网页链接
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223540 Size: 24 KB 网页链接